More recently, additional studies demonstrated that blockade of the IL-23 receptor (IL-23R) by either antibody or genetic approaches also reduced overall GVHD mortality and protected animals from pathological damage in the GI tract (52). The gene discussed is IL23R; the disease is graft versus host disease.